#$%^&*AU2013201069B120130815.pdf#####077350.0356 ABSTRACT OF THE DISCLOSURE The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt 5 thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation. NY02:746896, 1 -41-